Biomarkers and optimal management of heart failure in the aging population

Published

Book Section

© Springer Science+Business Media New York 2014. The incidence of heart failure (HF) increases with advancing age with a lifetime risk for the diagnosis of 20 %. There are physiological changes that predispose the elderly to developing HF and small insults may rapidly precipitate decompensation of symptoms. There are special challenges in diagnosing and managing elderly patients with HF, challenges that biomarkers can help mitigate. Natriuretic peptides such as B-type natriuretic peptide and N-terminal proBNP are established biomarkers that have been proven to accurately diagnose and prognosticate HF. There are additional promising novel biomarkers that may be of use.

Full Text

Duke Authors

Cited Authors

  • Gaggin, HK; Januzzi, JL

Published Date

  • January 1, 2014

Book Title

  • Aging and Heart Failure: Mechanisms and Management

Start / End Page

  • 135 - 146

International Standard Book Number 13 (ISBN-13)

  • 9781493902675

Digital Object Identifier (DOI)

  • 10.1007/978-1-4939-0268-2

Citation Source

  • Scopus